Middle East Intravenous Catheters Market Outlook (2022-2033)

The Middle East intravenous catheters market size is expected to reach US$ 515.0 million by 2033 from US$ 279.9 million in 2024. The market is estimated to record a CAGR of 7.0% from 2025 to 2033.

Executive Summary and Middle East Intravenous Catheters Market Analysis:

The intravenous catheters market in Middle East is experiencing significant growth driven by the increase in hospitalization and surgical procedures; especially in ICUs and oncology, higher adoption of peripherally inserted central catheters (PICCs) and midline catheters, and rising focus on infection control driving demand for coated/antimicrobial catheters. The Middle East intravenous catheters market is characterized by rapid modernization of healthcare systems, rising patient volumes, and strong government support for advanced medical technologies. Peripheral intravenous catheters dominate usage, reflecting their essential role in routine hospital care, emergency medicine, and outpatient procedures. Coated catheters are gaining traction as infection prevention becomes a priority, particularly in tertiary hospitals in Saudi Arabia, the United Arab Emirates, and Qatar, where international standards are closely followed. Multi‑lumen catheters are increasingly adopted in oncology and intensive care units, reflecting the region’s growing focus on complex therapies and advanced interventions. Hospitals and clinics represent the largest end‑user segment, supported by government initiatives to expand healthcare infrastructure and private sector investment in modern facilities. Competitive dynamics highlight the presence of multinational corporations such as BD, Teleflex, and Medtronic, alongside regional distributors who play a critical role in ensuring product accessibility in fragmented markets. Adoption patterns vary significantly: Saudi Arabia leads in demand due to its large population and government investment in healthcare modernization, while the UAE emphasizes innovation and premium adoption. Overall, the market reflects a balance of affordability, innovation, and infrastructure development, positioning the Middle East as a region of incremental but strategic growth for intravenous catheter manufacturers.

Middle East Intravenous Catheters Market Segmentation Analysis

Key segments that contributed to the derivation of the intravenous catheters market analysis are product, coating type, lumen, and end user.

• By product, the intravenous catheters market is segmented into peripheral catheter, central catheter, PICC catheter, and others. Peripheral catheter dominated the market in 2024, driven by the routine use in emergency and inpatient care across Middle Eastern hospitals.
• By coating type, the intravenous catheters market is segmented into coated catheters, uncoated catheters. Coated catheters dominated the market in 2024, driven by infection‑control mandates and preference for advanced biocompatible devices in tertiary centers.
• By lumen, the market is segmented into single-lumen, multi-lumen. Multi-lumen dominated the market in 2024, driven by the demand for efficiency in administering multiple therapies in critical care units.
• By end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, diagnostic imaging centers, and others. Hospitals & clinics dominated the market in 2024, driven by government‑funded healthcare expansion and private sector investment in modern facilities.

Middle East Intravenous Catheters Market Outlook

The Middle East intravenous catheters market is segmented into the United Arab Emirates, Saudi Arabia, Bahrain, Oman, Kuwait, Qatar, and Turkiye. ​‍​‌‍The outlook for the Middle East intravenous catheters market is highly positive, driven by demographic trends, healthcare reforms, and rising awareness of infection control. Aging populations in Saudi Arabia and the UAE will increase demand for intravenous therapies, while the growing burden of chronic diseases such as diabetes and cancer will further accelerate catheter utilization. Peripheral catheters will continue to dominate in emergency and routine care, but innovation in materials and coatings will enhance safety and reduce complications. Coated catheters are expected to see faster adoption as hospitals prioritize patient safety and align with international infection‑control standards. Multi‑lumen catheters will gain importance in tertiary hospitals, where complex therapies require efficiency and precision. Strategic opportunities lie in expanding catheter use in outpatient and ambulatory care centers, supported by government initiatives to decentralize healthcare delivery. Partnerships with NGOs and global health organizations will also play a role in improving access to intravenous devices in underserved regions. From a business perspective, companies must balance innovation with affordability, tailoring portfolios to meet diverse needs across Middle Eastern markets. Localization of manufacturing and distribution will be critical to overcoming supply chain challenges, while training programs for healthcare professionals will ensure proper catheter usage and reduce complications. The long‑term outlook positions the Middle East as a growth frontier where companies that invest in education, affordability, and infrastructure partnerships will secure competitive advantage.

Middle East Intravenous Catheters Market Country Insights

Based on region, the Middle East intravenous catheters market is further segmented into the United Arab Emirates, Saudi Arabia, Bahrain, Oman, Kuwait, Qatar, and Turkiye. Turkiye held the largest share in 2024.

Country‑level dynamics in the Middle East reveal diverse adoption patterns shaped by healthcare infrastructure, government priorities, and private sector participation. Turkiye & Saudi Arabia lead the region, supported by advanced hospitals and strong private healthcare investment, driving demand for coated and multi‑lumen catheters in intensive care units. United Arab Emirates represents a high‑potential market, where affordability and distribution efficiency are critical success factors, as intravenous therapy is widely used in both urban and rural hospitals. Qatar emphasizes modernization, with government programs expanding catheterization labs and infection‑control initiatives, boosting demand for coated catheters. Kuwait and Oman are gradually scaling adoption, supported by NGO‑led programs and regional hospital networks that emphasize minimally invasive care. Smaller markets such as Bahrain are witnessing incremental growth, driven by government investment in tertiary hospitals and training programs for clinicians. Across these countries, hospitals and clinics remain the dominant end‑users, but private diagnostic centers are increasingly investing in intravenous catheter technologies to expand service offerings. The diversity of country insights underscores the need for differentiated strategies: premium positioning in Saudi Arabia and UAE, affordability in Oman and Kuwait, and partnership‑driven expansion in emerging economies. Collectively, the Middle East’s country‑level dynamics highlight a spectrum of opportunities where localized approaches, strong distribution networks, and education initiatives are essential for sustained success.

Middle East Intravenous Catheters Market Company Profiles

Mediplus India Ltd, Boston Scientific Corp, Becton Dickinson and Co, Teleflex Inc, B Braun SE, Sterimed Medical Devices Pvt Ltd, Terumo Corp, Angiplast, Cook Medical Holdings LLC, ICU Medical Inc, are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

Middle East Intravenous Catheters Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Middle East Intravenous Catheters Key Sources Referred:

• World Health Organization (WHO)
• World Heart Federation (WHF)
• Organisation for Economic Cooperation and Development (OECD)
• The World Bank Group
• Worldometer
• The Lancet
• International Bar Association
• International Trade Administration
• Eurostat